Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results* for: March 26, 2008

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Combigan New Drug Initial Review Require Prior Approval Prior Approval Required
Iquix New Drug Initial Review Require Prior Approval Prior Approval Required
Lipofen New Drug Initial Review Require Prior Approval Prior Approval Required
ProAir HFA PDL Appeal Remain Non-Preferred Non-Preferred � PDL Class
Saizen PDL Appeal Remain Non-Preferred Non-Preferred � PDL Class
Sanctura XR New Drug Initial Review Require Prior Approval Prior Approval Required
Simcor New Drug Initial Review Require Prior Approval Prior Approval Required
Tekturna New Drug Initial Review Require Prior Approval Prior Approval Required
Vusion New Drug Initial Review Require Prior Approval Prior Approval Required